Global Nanobiotechnology Market 2018-2022

Global Nanobiotechnology Industry Overview

There is a growing need to combat various emerging rare diseases and discover new therapies for existing conditions and the pharmaceutical industry is witnessing a significant rise in investments towards research. Additionally, there is also an increase in investments made in the R&D for biotechnology companies. The US is the largest investor in biotechnology and has invested a total amount of about USD 30 billion in 2015. France is another major investor and the country has witnessed an investment of almost USD 4 billion. With the growing trend of increased R&D spending, the demand for nanobiotechnology will increase during the forecast period, fueling market growth.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Companies covered

The nanobiotechnology market is moderately fragmented with the presence of a considerable number of companies that offer products such as nanobodies, carbon nanotubes, and probes. This nanotechnology market is currently in the growth phase and as a result, the market’s competitive environment will intensify in the coming years. By providing an analysis of the market’s competitive landscape and offering information on products offered by companies, tis nanotechnology industry analysis report will help clients identify new growth opportunities and design strategies to make the most from the growing demand.

The report offers a complete analysis of nanotechnology companies including:

• Ablynx
• CELGENE
• Merck KGaA
• Thermo Fisher Scientific

Nanobiotechnology market growth based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the upcoming growth opportunities for companies across regions such as the Americas, APAC, and EMEA, our industry research analysts have estimated that countries in the Americas will contribute to the maximum growth of the nanobiotechnology market throughout the predicted period. The growth of the market in this region will mainly attribute to the availability of advanced healthcare infrastructure that can easily adopt nanotechnology.

Nanobiotechnology market growth based on end-user

• Pharmaceuticals and biotechnology industry
• Medical devices

According to our market research experts, the pharmaceuticals and biotechnology industry segment will account for the maximum share of the market. Rising expenditure in pharmaceutical and biotechnology sectors is driving the growth for the nanobiotechnology market in this region.

Key highlights of the global nanobiotechnology market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the nanobiotechnology market during the next five years
• Precise estimation of the global nanobiotechnology market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• Growth of the nanobiotechnology industry across various geographies such as the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive information about factors that will challenge the growth of nanotechnology companies

Get more value with Technavio’s INSIGHTS subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Try the demo

This market research report analyzes the market outlook and provides a list of key trends, drivers, and challenges that are anticipated to impact the global nanobiotechnology market and its stakeholders over the forecast years.

Technavio’s analysts have also considered how the performance of other related markets in the vertical will impact this nanotechnology market size till 2022. One of the markets most likely to influence the growth of nanotechnology market in biological phenomena over the coming years is the nanoparticles market in biotechnology and pharmaceutical sectors.

Technavio also provides customized reports based on the specific requirements of clients.